MEP26708A - Orlani farmaceutski preparati sa fungicidnim dejstvom i postupak za njegovo pripremanje - Google Patents

Orlani farmaceutski preparati sa fungicidnim dejstvom i postupak za njegovo pripremanje

Info

Publication number
MEP26708A
MEP26708A MEP-267/08A MEP26708A MEP26708A ME P26708 A MEP26708 A ME P26708A ME P26708 A MEP26708 A ME P26708A ME P26708 A MEP26708 A ME P26708A
Authority
ME
Montenegro
Prior art keywords
coating
preparation
compound
inert
pharmaceutical oral
Prior art date
Application number
MEP-267/08A
Other languages
English (en)
Inventor
Darder Carlos Picornell
Original Assignee
Liconsa Liberacion Controlada De Sustancias Activas S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8304581&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MEP26708(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Liconsa Liberacion Controlada De Sustancias Activas S A filed Critical Liconsa Liberacion Controlada De Sustancias Activas S A
Publication of MEP26708A publication Critical patent/MEP26708A/bs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Sadrži jedinjenje sa fungicidnim delovanjem kao aktivni sastojak, inertna jezgra i prevlaku, koja uključuje pomenuti aktivni sastojak, i naznačen je time što pomenuta inertna jezgra imaju dimenzije čestica izmedju 50 i 600 μm, i što se pomenuta prevlaka sastoji od samo jednog sloja dobijenog naprskavanjem na inertna jezgra u rastvoru koji sadrži jedinjenje sa fungicidnim dejstvom, hidrofilni polimer i nejonski surtaktant. Postupak se sastoji od sprovodjenja prevlačenja inertnih jezgara u jednom sloju, pri čemu je dimenzija jezgara izmedju 50 i 600 μm, postupkom naprskavanja jednog rastvora sastavljenog od fungicidnog sredstva, hidrofilnog polimera u nejonskog surfaktanta, stalnom brzinom prevlačenja tokom celog postupka; i jednog jedinog koraka sušenja prevlake u istoj aparaturi.
MEP-267/08A 1998-07-21 1999-07-20 Orlani farmaceutski preparati sa fungicidnim dejstvom i postupak za njegovo pripremanje MEP26708A (bs)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES009801539A ES2157731B1 (es) 1998-07-21 1998-07-21 Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion.
PCT/ES1999/000230 WO2000004881A1 (es) 1998-07-21 1999-07-20 Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion

Publications (1)

Publication Number Publication Date
MEP26708A true MEP26708A (bs) 2010-06-10

Family

ID=8304581

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-267/08A MEP26708A (bs) 1998-07-21 1999-07-20 Orlani farmaceutski preparati sa fungicidnim dejstvom i postupak za njegovo pripremanje

Country Status (31)

Country Link
US (1) US6737082B1 (bs)
EP (1) EP1103252B1 (bs)
JP (1) JP4190732B2 (bs)
KR (1) KR100572135B1 (bs)
AT (1) ATE234077T1 (bs)
AU (1) AU750730B2 (bs)
BG (1) BG65187B1 (bs)
BR (1) BR9912300A (bs)
CA (1) CA2337509C (bs)
CZ (1) CZ291938B6 (bs)
DE (1) DE69905905T2 (bs)
DK (1) DK1103252T3 (bs)
EE (1) EE04415B1 (bs)
ES (2) ES2157731B1 (bs)
HK (1) HK1037531A1 (bs)
HR (1) HRP20010128B1 (bs)
HU (1) HU228895B1 (bs)
IL (1) IL140910A (bs)
ME (1) MEP26708A (bs)
MX (1) MXPA01000681A (bs)
NO (1) NO320054B1 (bs)
NZ (1) NZ509886A (bs)
PL (1) PL194740B1 (bs)
PT (1) PT1103252E (bs)
RS (1) RS50063B (bs)
RU (1) RU2209628C2 (bs)
SK (1) SK283279B6 (bs)
TR (1) TR200100177T2 (bs)
UA (1) UA64009C2 (bs)
WO (1) WO2000004881A1 (bs)
ZA (1) ZA200101293B (bs)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5997915A (en) * 1996-01-31 1999-12-07 South Alabama Medical Science Foundation Compositions for human and animal consumption containing reduced folates and methods for making and using same
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
EP1712222A3 (en) 1999-12-23 2012-06-20 Pfizer Products Inc. Pharmaceutical compositions providing enhanced drug concentrations
FR2842736B1 (fr) 2002-07-26 2005-07-22 Flamel Tech Sa Formulation pharmaceutique orale sous forme d'une pluralite de microcapsules permettant la liberation prolongee de principe(s) actif(s) peu soluble(s)
US20040115287A1 (en) * 2002-12-17 2004-06-17 Lipocine, Inc. Hydrophobic active agent compositions and methods
DE60312635T3 (de) * 2003-01-14 2013-05-08 Cimex Pharma Ag Zusammensetzung in Form eines festen Dispersion enthaltend Itraconazol und ein hydrophilisches Polymer mit einer verbesserten Bioverfügbarkeit
PT1438961E (pt) * 2003-01-14 2007-05-31 Cimex Pharma Ag Composição bioquivalente de itraconazol disperso num polímero hidrofílico.
FR2852607B1 (fr) * 2003-03-20 2006-07-14 Procede de fabrication de microspheres de sucre de petite taille, les microspheres susceptibles d'etre obtenues par ce procede et leurs applications
FR2857591B1 (fr) * 2003-07-17 2007-11-02 Ethypharm Sa Particules comprenant un principe actif sous forme de co-precipite
US20060172010A1 (en) * 2003-07-17 2006-08-03 Gael Lamoureux Process for preparing particles containing an antiviral
FR2883179B1 (fr) 2005-03-18 2009-04-17 Ethypharm Sa Comprime enrobe
AU2006283040B2 (en) 2005-08-22 2011-08-25 The Johns Hopkins University Hedgehog pathway antagonists to treat disease
CN101283984B (zh) * 2007-04-12 2010-05-26 永胜药品工业股份有限公司 高生物使用率的经杀真菌剂和聚合物涂覆的核心微粒状物
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
WO2011107466A2 (de) * 2010-03-05 2011-09-09 Basf Se Schmelzüberzogene arzneiformen
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
WO2016033556A1 (en) 2014-08-28 2016-03-03 Lipocine Inc. BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
WO2016033549A2 (en) 2014-08-28 2016-03-03 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
MA40982A (fr) * 2014-11-19 2017-09-26 Biogen Ma Inc Formulation de bille pharmaceutique comprenant du fumarate de diméthyle
MX2017015137A (es) * 2015-05-25 2018-03-28 Sun Pharmaceutical Ind Ltd Composicion farmaceutica oral de dosis diaria de isotretinoin.
AU2017310506B2 (en) 2016-08-11 2019-11-21 Dmk Pharmaceuticals Corporation Drug compositions
JP2020503269A (ja) 2016-11-28 2020-01-30 リポカイン インコーポレーテッド 経口ウンデカン酸テストステロン療法
US11564910B2 (en) 2017-12-08 2023-01-31 Adamis Pharmaceuticals Corporation Drug compositions
CN112313289A (zh) * 2018-04-27 2021-02-02 凸版印刷株式会社 缓释性复合颗粒、缓释性复合颗粒的制造方法、干燥粉体、以及壁纸
WO2023118082A1 (en) * 2021-12-22 2023-06-29 Palau Pharma, S.L.U. Multiparticulate albaconazole composition

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4218458A (en) * 1978-06-23 1980-08-19 Janssen Pharmaceutica, N.V. Heterocyclic derivatives of (4-aryloxy-methyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles
US4916134A (en) * 1987-03-25 1990-04-10 Janssen Pharmacuetica N.V. 4-[4-[4-[4-[[2-(2,4-difluorophenyl)-2-(1H-azolylmethyl)-1,3-dioxolan-4-yl]me]phenyl]-1-piperazinyl]phenyl]triazolones
IE61651B1 (en) * 1990-07-04 1994-11-16 Zambon Spa Programmed release oral solid pharmaceutical dosage form
PH30929A (en) * 1992-09-03 1997-12-23 Janssen Pharmaceutica Nv Beads having a core coated with an antifungal and a polymer.
US5567441A (en) * 1995-03-24 1996-10-22 Andrx Pharmaceuticals Inc. Diltiazem controlled release formulation
CN1165291C (zh) * 1996-05-20 2004-09-08 詹森药业有限公司 具有改进的生物利用度的抗真菌组合物
CA2255663C (en) * 1996-05-24 2002-08-20 Schering Corporation Antifungal composition with enhanced bioavailability
TR199802718T2 (xx) * 1996-06-28 1999-03-22 Schering Corporation Bir triazol mantara kar�� bile�i�ini i�eren a��zdan al�nan bile�im.
DE19626924C2 (de) * 1996-07-04 1999-08-19 Epazon B V Gerät zur Bereitstellung eines Atemgases
HU224217B1 (hu) * 1997-03-26 2005-06-28 Janssen Pharmaceutica N.V. Gombaellenes hatóanyaggal és polimerrel bevont magrészt tartalmazó pelletek

Also Published As

Publication number Publication date
PL194740B1 (pl) 2007-06-29
HUP0103708A3 (en) 2002-07-29
CA2337509C (en) 2005-12-27
JP2002521323A (ja) 2002-07-16
ES2157731A1 (es) 2001-08-16
ZA200101293B (en) 2001-08-21
HU228895B1 (en) 2013-06-28
HRP20010128B1 (en) 2003-12-31
AU4782199A (en) 2000-02-14
HRP20010128A2 (en) 2002-12-31
HK1037531A1 (en) 2002-02-15
RU2209628C2 (ru) 2003-08-10
MXPA01000681A (es) 2002-04-24
EE04415B1 (et) 2005-02-15
NO320054B1 (no) 2005-10-17
KR100572135B1 (ko) 2006-04-19
DE69905905T2 (de) 2004-03-04
UA64009C2 (en) 2004-02-16
TR200100177T2 (tr) 2001-07-23
SK862001A3 (en) 2001-08-06
BG65187B1 (bg) 2007-06-29
ATE234077T1 (de) 2003-03-15
NO20010289D0 (no) 2001-01-17
ES2194480T3 (es) 2003-11-16
US6737082B1 (en) 2004-05-18
DE69905905D1 (de) 2003-04-17
IL140910A (en) 2004-03-28
DK1103252T3 (da) 2003-07-14
AU750730B2 (en) 2002-07-25
CZ2001175A3 (en) 2001-05-16
BG105282A (en) 2001-11-30
KR20010070990A (ko) 2001-07-28
HUP0103708A2 (hu) 2002-02-28
EP1103252A1 (en) 2001-05-30
ES2157731B1 (es) 2002-05-01
PL345625A1 (en) 2002-01-02
RS50063B (sr) 2009-01-22
YU3901A (sh) 2003-08-29
NZ509886A (en) 2002-09-27
CA2337509A1 (en) 2000-02-03
WO2000004881A1 (es) 2000-02-03
IL140910A0 (en) 2002-02-10
JP4190732B2 (ja) 2008-12-03
EP1103252B1 (en) 2003-03-12
BR9912300A (pt) 2001-04-17
PT1103252E (pt) 2003-07-31
SK283279B6 (sk) 2003-05-02
CZ291938B6 (cs) 2003-06-18
EE200100041A (et) 2002-06-17
NO20010289L (no) 2001-03-07

Similar Documents

Publication Publication Date Title
MEP26708A (bs) Orlani farmaceutski preparati sa fungicidnim dejstvom i postupak za njegovo pripremanje
EA200300999A1 (ru) Хронотерапевтические дозированные формы
DK1059848T3 (da) Dragéret tyggegummi, fremgangsmåde til fremstilling hraf samt anvendelse af et eller flere aktive stoffer i fast form
CA2370067A1 (en) Pharmaceutical dosage forms for controlled release producing at least a timed pulse
DK2332523T3 (da) Ensartede film til hurtigtopløsende doseringsform indeholdende smagsmaskerende præparater
ATE412437T1 (de) Silber enthaltende zusammensetzungen, geräte und verfahren zu deren herstellung
JP2003512395A5 (bs)
WO2004012699A3 (en) Modified release composition comprising coated micro matrix particles containing the high soluble active ingredient and a release controlling agent
SI0868912T1 (en) Use of redispersible polymer powders or polymer granulates for coating pharmaceutical or agrochemical delivery forms
UA95993C2 (ru) Композиция пеллеты пролонгированного высвобождения, которая содержит прамипексол или его фармацевтически приемлемую соль, способ ее изготовления и ее применение
BG104193A (en) Peroral pharmaceutical preparation including a compound with antiulcerous activity, and method for its preparation
NZ515230A (en) Fast-dispersing dosage forms containing fish gelatin
SE9702000D0 (sv) New pharmaceutical formulation
ATE341320T1 (de) Pharmazeutische zusammensetzung enthaltend fenofibrat und verfahren zu deren herstellung
WO2005027843A3 (en) Chronotherapeutic dosage forms
RU2001104894A (ru) Пероральная фармацевтическая композиция на основе соединения, имеющего антигрибковую активность, и способ ее получения
SE0100200D0 (sv) New film coating
FR2816507B1 (fr) Microgranules a base de principe actif, procede de fabrication et compositons pharmaceutiques integrant lesdits microgranules
FI101855B1 (fi) Menetelmä asetatsolamidia jatkuvasti vapauttavan asetatsolamidivalmisteen valmistamiseksi
JPS5215819A (en) Gramineae weeds controlling agent